Received Feb 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
never received his second; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose of Shingrix vaccine in 2023). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: never received his second ). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 25-FEB-2025 The reporter reported that patient stated that he received his first dose of Shingrix in 2023 and never received his second because he moved. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.